Stockscreener 앱 받기
3.44
4.88%
0.16
시장 영업 전:
3.48
0.04
+1.16%
전일 마감가:
$3.28
열려 있는:
$3.25
하루 거래량:
40,076
Relative Volume:
0.08
시가총액:
$7.17M
수익:
-
순이익/손실:
$-14.58M
주가수익비율:
-2.9913
EPS:
-1.15
순현금흐름:
$-9.80M
1주 성능:
-8.27%
1개월 성능:
-28.63%
6개월 성능:
-51.55%
1년 성능:
-77.63%
1일 변동 폭
$3.1727
$3.45
1주일 범위
$3.1713
$3.94
52주 변동 폭
$3.1713
$25.00
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
명칭
Acurx Pharmaceuticals Inc
전화
917-533-1469
주소
259 LIBERTY AVENUE, STATEN ISLAND
ACXP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
3.44 | 6.84M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Acurx Pharmaceuticals Inc 주식(ACXP)의 최신 뉴스
Will Acurx Pharmaceuticals Inc. (3ZO) stock beat growth indexesAnalyst Downgrade & Long-Term Safe Investment Plans - Newser
Will Acurx Pharmaceuticals Inc. (3ZO) stock draw ESG focused fundsWeekly Trend Summary & AI Based Trade Execution Alerts - Newser
Will Acurx Pharmaceuticals Inc. (3ZO) stock justify high valuation2025 Stock Rankings & Weekly Breakout Stock Alerts - Newser
Is Acurx Pharmaceuticals Inc. stock a defensive play in 2025Entry Point & Verified Short-Term Plans - Newser
Will Acurx Pharmaceuticals Inc. (3ZO) stock beat Nasdaq index returns - Newser
Is Acurx Pharmaceuticals Inc. stock positioned for long term growthShort Setup & High Accuracy Trade Alerts - BỘ NỘI VỤ
Perhaps timely catching Acurx Pharmaceuticals Inc (ACXP) would be a good idea - Setenews
Why Acurx Pharmaceuticals Inc. (3ZO) stock could break out in 2025July 2025 Selloffs & Reliable Momentum Entry Alerts - BỘ NỘI VỤ
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - Daytona Beach News-Journal
Wall Street Zen Upgrades Acurx Pharmaceuticals (NASDAQ:ACXP) to Hold - Defense World
Acurx Pharmaceuticals Inc. (ACXP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Acurx Pharmaceuticals Inc. (3ZO) stock is upgraded to buy2025 Bull vs Bear & Free Long-Term Investment Growth Plans - newser.com
Is Acurx Pharmaceuticals Inc. (3ZO) stock a defensive play amid uncertaintyInsider Buying & Weekly Market Pulse Alerts - newser.com
Will Acurx Pharmaceuticals Inc. stock benefit from green energy trendsPortfolio Gains Report & Step-by-Step Trade Execution Guides - newser.com
Can Acurx Pharmaceuticals Inc. (3ZO) stock withstand sector downturnsJuly 2025 Fed Impact & Daily Growth Stock Tips - newser.com
What is the fair value of Acurx Pharmaceuticals Inc. stock nowTrade Exit Summary & Long Hold Capital Preservation Tips - newser.com
Is Acurx Pharmaceuticals Inc. stock resilient to inflationTrade Volume Report & High Conviction Buy Zone Picks - newser.com
Is Acurx Pharmaceuticals Inc. (3ZO) stock positioned for digital growth eraEarnings Risk Summary & Safe Entry Zone Tips - newser.com
Why Acurx Pharmaceuticals Inc. (3ZO) stock could be next leaderJuly 2025 Macro Moves & Entry and Exit Point Strategies - newser.com
Quantitative breakdown of Acurx Pharmaceuticals Inc. recent moveTrade Risk Assessment & Precise Entry and Exit Recommendations - newser.com
Is this a good reentry point in Acurx Pharmaceuticals Inc.July 2025 Snapshot & Advanced Swing Trade Entry Plans - newser.com
How to interpret RSI for Acurx Pharmaceuticals Inc. stockJuly 2025 Sentiment & Fast Gain Swing Trade Alerts - newser.com
Can Acurx Pharmaceuticals Inc. stock maintain operating margins2025 Biggest Moves & Verified Entry Point Signals - newser.com
Pattern recognition hints at Acurx Pharmaceuticals Inc. upsideLayoff News & Scalable Portfolio Growth Methods - newser.com
Acurx Pharmaceuticals Inc (ACXP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.10%
1.10%
자본화:
|
볼륨(24시간):